Abstract # 1075 A Phase II Trial of Full-Dose Gemcitabine with Concurrent Radiation Therapy in Patients with Resectable or Unresectable Non-Metastatic Pancreatic Cancer

Presenter: Small, William

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

About the Presenter:
Associate Professor and Vice-Chairman of Radiation Oncology Associate Medical Director, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Contact the presenter at: w-small@northwestern.edu

Authors:
W. Small*1, M. Talamonti*1, D. Normolle*2, G. Freedman*3, J. Berlin*4, T. Kinsella*5, P. Philip*6, M. Zalupski*7, M. Mulcahy*1, N. Meropol*3. , 1Northwestern University Medical School, Chicago, IL, 2University of Michigan, AnnArbor, MI, 3Fox Chase Cancer Center, Philadelphia, PA, 4Vanderbilt University Medical Center, Nashville, TN, 5Case Western Reserve University, Cleveland, OH, 6Karmanos Cancer Institute, Detroit, MI, 7University of Michigan, Ann Arbor, MI,

Author Disclosure:
W. Small, Eli Lilly and Co., B. Research Grant; Genetech, B. Research Grant; Medimmune, D. Speakers Bureau/Honoraria; M. Talamonti, Eli Lilly and Co., B. Research Grant; D. Normolle, Eli Lilly and Co., B. Research Grant; G. Freedman, Eli Lilly and Co., B. Research Grant; J. Berlin, Eli Lilly and Co., B. Research Grant; T. Kinsella, Eli Lilly and Co., B. Research Grant; P. Philip, Eli Lilly and Co., B. Research Grant; M. Zalupski, Eli Lilly and Co., B. Research Grant; M. Mulcahy, Eli Lilly and Co., B. Research Grant; N. Meropol, Eli Lilly and Co., B. Research Grant.


E-mail a friend about this abstract:
Enter email address:   



Abstracts Main Page | Logout